Rigel Pharmaceuticals (RIGL) Shares Outstanding (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Shares Outstanding (Entity) of $18.5 million for Q1 2026, up 3.52% year-over-year from $17.9 million in Q1 2025, and up 1.04% quarter-over-quarter from $18.3 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Shares Outstanding (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $18.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 3.52% year-over-year to $18.5 million; the TTM figure through Mar 2026 stood at $18.5 million (up 3.52% YoY), while the FY2025 annual figure was $18.3 million, up 3.39% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $18.5 million, up from $18.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $18.5 million in Q1 2026, with the low at $17.2 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $17.5 million (2024), against an average of $17.7 million.
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) climbed 0.82% in 2023, then advanced 3.52% in 2026.
- Rigel Pharmaceuticals' Shares Outstanding (Entity) stood at $17.3 million in 2022, then gained by 0.82% to $17.5 million in 2023, then gained by 1.3% to $17.7 million in 2024, then advanced by 3.39% to $18.3 million in 2025, then increased by 1.04% to $18.5 million in 2026.
- Business Quant data shows RIGL's Shares Outstanding (Entity) at $18.5 million in Q1 2026, $18.3 million in Q4 2025, and $18.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 18.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.54 Mn |
| Mar 31, 2026 | 18.41 Mn |
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 18.04 Mn |
| Jun 30, 2025 | 17.89 Mn |
| Mar 31, 2025 | 17.81 Mn |
| Dec 31, 2024 | 17.58 Mn |
| Sep 30, 2024 | 17.60 Mn |
| Jun 30, 2024 | 17.55 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 17.44 Mn |
| Jun 30, 2023 | 17.37 Mn |
| Mar 31, 2023 | 17.36 Mn |
| Dec 31, 2022 | 17.24 Mn |
| Sep 30, 2022 | 17.28 Mn |
| Jun 30, 2022 | 17.21 Mn |
| Mar 31, 2022 | 17.18 Mn |
| Dec 31, 2021 | 17.05 Mn |
| Sep 30, 2021 | 17.09 Mn |